
Introduction
Retatrutide is the most searched weight-loss drug of November 2026: searches have risen more than ninefold in a year, because in the largest trial so far, people taking the highest dose lost an average of one quarter of their body weight in 80 weeks. Retatrutide is a once-weekly injection made by Eli Lilly that switches on three hormone receptors at once, GIP, GLP-1 and glucagon, the first drug of its kind. It is not yet approved by any regulator, and it cannot legally be bought, prescribed or compounded. This guide explains what it is, how it works, what the trials showed, and what to do while you wait. Medically reviewed by Dr. Ata Ullah, MD (Medicine).
What Happened in November 2026
On 8 November 2026, the newest trial results were published in the New England Journal of Medicine and presented at the American College of Rheumatology meeting in Orlando. In the TRIUMPH-4 trial, 445 adults with painful knee osteoarthritis and obesity took retatrutide or a placebo for 68 weeks. The highest dose cut body weight by almost 24% and eased knee pain at the same time, a first for a weight-loss drug. That result is why retatrutide is suddenly everywhere in the news.
What Causes Obesity, and What Retatrutide Is For
Obesity is not a failure of willpower. It happens when the body stores more energy than it uses, over years, and the reasons are usually several at once. Genes set appetite and how the body stores fat. Some medicines add weight, including steroids and some antidepressants. Short sleep and chronic stress push hunger hormones up. Cheap, calorie-dense food is everywhere, and work is mostly sitting. An underactive thyroid can also slow metabolism. The scale of the problem is large: the World Health Organization reports that 1 in 8 people in the world lived with obesity in 2022, 890 million adults, and the CDC puts adult obesity in the United States at 40.3%.
Obesity raises the risk of type 2 diabetes, heart disease, stroke, sleep apnoea, fatty liver disease, painful knee osteoarthritis and several cancers, which is why a drug that cuts weight by a quarter matters so much. Even a 5 to 10% loss already improves blood sugar, blood pressure and joint pain. Retatrutide was tested in adults with obesity, and in overweight adults with a condition such as diabetes or knee osteoarthritis. Our guide to type 2 diabetes warning signs explains the condition its second large trial was designed around.
How Retatrutide Works in the Body
Retatrutide is one molecule built to switch on three hormone receptors at once, a triple agonist. The first is the GLP-1 receptor, the same target as semaglutide: it slows the emptying of the stomach, lowers appetite, and helps the pancreas release insulin when blood sugar rises. The second is the GIP receptor, which also supports insulin release and helps the body handle fat. The third is the glucagon receptor, which raises energy expenditure and helps the liver burn fat. It is given as a once-weekly injection under the skin, and the dose is raised in steps over weeks so the body can adjust.
The three actions reinforce each other. Eating less lowers weight, and burning more energy and fat in the liver adds to the loss. As weight falls, blood sugar steadies, blood pressure falls, triglycerides fall, and the load on painful knees drops, which is why knee pain improved in the trials. One effect needs watching: heart rate rises slightly in a dose-dependent way, peaking at 24 weeks in the phase 2 trial before settling. Semaglutide switches on one receptor, tirzepatide two; retatrutide is the first to switch on three, and that extra glucagon action is why its weight loss is the largest seen.
Prevention: What You Can Do While Retatrutide Is Not Yet Available
The honest starting point is that the habits which prevent obesity complications are still the base, with or without a new drug. Eat mostly whole foods, keep portions moderate, and move most days: about 150 minutes of brisk walking a week plus strength training twice a week protects muscle and joints. Sleep seven to nine hours: short sleep raises hunger the next day. Track weight, blood pressure and blood sugar, and have them checked at every visit. Small changes that last beat large changes that stop after a month.
Do not buy retatrutide online. Products sold online as “research peptide” retatrutide are not made by Eli Lilly, are unregulated, and may contain the wrong substance or strength, or harmful contaminants. Drugs.com warns that any retatrutide sold outside a clinical trial is not legitimate and may be dangerous to your health. Retatrutide exists today only inside clinical trials.
Approved options already exist, and your doctor can discuss them now. Semaglutide and tirzepatide are prescribed for weight management and diabetes, and the once-daily GLP-1 pill orforglipron, sold as Foundayo, is now approved for weight management: our guide to orforglipron for sleep apnea explains its trial results in full. Do not stop any prescribed diabetes, blood pressure or cholesterol medicine while you wait for a new drug; sudden stops can spike blood sugar and blood pressure. If knee pain is your main problem, ask about physiotherapy and strength work now: stronger leg muscles protect the joint.
Side Effects and Warning Signs
The most common side effects in the trials were digestive, and they rose with the dose and after each step up. In TRIUMPH-1, nausea affected 29 to 42% against 15% on placebo, diarrhoea 25 to 34%, constipation 24 to 26%, and vomiting 11 to 25%. Reduced appetite was also common, which can make eating and drinking enough hard. These effects were mostly mild to moderate and improved over time. About 11 in 100 people on the highest dose stopped the drug because of side effects, against 5 in 100 on placebo.
A less familiar side effect is dysesthesia, an unusual skin sensation such as tingling, burning or sensitivity to touch, reported by about 5 to 13% of people on retatrutide. Tiredness and a slightly faster heartbeat were also seen. Phase 2 body-composition data carry a warning: about 30 to 40% of the weight lost was lean tissue, not fat, which is why protein and strength training matter during rapid weight loss.
| Side effect | How common | What to do |
|---|---|---|
| Nausea | 29-42% | Small, frequent meals; tell your doctor if it persists |
| Diarrhoea or constipation | 25-34% / 24-26% | Keep drinking water; seek advice if severe |
| Vomiting | 11-25% | Sip fluids; seek care if fluids will not stay down |
| Skin tingling (dysesthesia) | 5-13% | Report it to your doctor |
| Reduced appetite | Common | Eat small amounts regularly |
Some symptoms need urgent care: severe, persistent pain in the upper abdomen can mean inflammation of the pancreas. Pain in the upper right abdomen, especially after a fatty meal, can mean gallbladder trouble. Swelling of the face or lips, or trouble breathing, can mean an allergic reaction: call emergency services at once. Shakiness, sweating and confusion can mean low blood sugar if you also take diabetes medicines. Persistent vomiting with dizziness and very little urine means dehydration, and also needs same-day care.
Tests and Monitoring
Before any weight-loss medicine is started, a doctor measures the baseline that later results are judged against. Body mass index and waist size are recorded, along with blood pressure and heart rate. Blood tests include HbA1c and fasting glucose for blood sugar, a lipid profile for cholesterol and triglycerides, liver function tests, kidney function tests, and a thyroid check, because an underactive thyroid can explain weight gain. A pregnancy test is done where relevant. If you snore loudly or wake up tired, a sleep study measures the apnoea-hypopnoea index, the number of breathing pauses per hour, and if your knees hurt, an X-ray and a WOMAC pain score record how bad the osteoarthritis is.
During treatment, weight, blood pressure and heart rate are checked at each visit, and HbA1c is repeated every three to six months. In the TRIUMPH-1 trial, the highest dose cut fasting insulin by about 59%, a marker of inflammation called hsCRP by about 64%, triglycerides by 41%, and systolic blood pressure by about 12 mmHg, so these are the numbers a doctor watches to see whether the drug is helping beyond the scale. Lipid and liver tests are repeated, and a gallbladder ultrasound is done if pain appears in the upper right abdomen. The trial programme is registered at ClinicalTrials.gov, where the design and the endpoints are listed. If blood sugar falls too far, or the heart rate stays high, the doctor changes the plan rather than pushing on with the same dose.
Treatment: How Retatrutide Fits Into Obesity Care
Retatrutide is not a treatment you can receive today: it is investigational, and no regulator has approved it for any use. Eli Lilly plans to file for approval in the first quarter of 2027, and a decision would not be due before about September 2027. The heart-and-kidney outcomes trial, TRIUMPH-Outcomes, is still running; no trial has yet shown fewer heart attacks or strokes.
Until approval, obesity care uses the tools that already exist: food and activity changes, approved medicines such as semaglutide and tirzepatide, and bariatric surgery. No head-to-head trial against semaglutide exists yet, and the trial against tirzepatide, TRIUMPH-5, has not reported, so “best drug” claims rest on comparing different trials, which can mislead. If approved, it would be prescription-only, started low and raised in steps.
From the Clinic: What a Physician Would Tell You
Do not wait for a miracle drug while weight harms your health. The 25% figure is a trial average, not a promise, and it came with nausea, tingling and a faster heartbeat for many. The knee-pain result matters more than the headline number, because pain is what stops people moving. If you are offered retatrutide on the internet, it is not the trial drug. The useful steps today are an approved medicine if your doctor advises one, protein and strength training, and a plan for keeping the weight off.
Emergency Medicines Guide
No emergency medicine treats these side effects directly. The medicines below are for the emergencies they can hide. Never take another person’s medicine: dosage must come from your doctor or pharmacist.
| Symptom | Medicine class |
|---|---|
| Severe nausea or vomiting | Antiemetic class |
| Severe, persistent abdominal pain | Hospital assessment only |
| Face or lip swelling, trouble breathing | Emergency adrenaline class, in hospital |
| Shakiness, sweating, confusion | Fast-acting glucose class |
| Upper right abdominal pain after fatty meals | Hospital assessment; do not self-treat |
Seek emergency care the same day for any of these symptoms, and tell the team every medicine you take.
What to Eat
Food matters twice over with a drug like this: it eases the nausea, and it protects the muscle that rapid weight loss can cost. Put protein at every meal, eggs, fish, chicken, beans, lentils or yoghurt, because protein plus strength training is what keeps muscle while fat falls. Eat small, frequent meals rather than three large ones, which is the single most useful trick for nausea, and eat slowly, stopping when you are comfortably full. Fibre from vegetables, oats and beans steadies blood sugar and keeps the bowels moving, which helps both constipation and diarrhoea, so do not skip vegetables even when your appetite is small.
Oily fish such as salmon and sardines twice a week adds omega-3 fats: triglycerides fell by 41% on the highest dose in the trials, and fish supports that change, so our guide to lowering cholesterol without medication is a useful companion. Drink water through the day instead of sugary drinks, keep salt moderate, and note what you eat for the first weeks, because nausea makes it easy to eat too little. If you cannot face a full meal, a small protein-rich snack, such as yoghurt or a boiled egg, is better than nothing.
What to Avoid
Never buy retatrutide, or any “research peptide”, from an online seller: the product is unregulated, it is not the trial drug, and it may be dangerous. Avoid alcohol while your appetite is low, because it worsens nausea and dehydration and adds empty calories. Avoid large, fatty meals, which trigger nausea and can provoke gallbladder pain. Avoid sugary drinks and crash diets: a crash diet costs more muscle and the weight returns faster. Do not skip meals and then overeat late at night, and do not stop a prescribed diabetes or blood pressure medicine without asking your doctor. Avoid herbal weight-loss products and appetite suppressants as well, because untested combinations can strain the heart and liver, and never weigh yourself many times a day: daily swings only add stress, so one weekly weigh-in is enough. Avoid starting any new supplement or herbal remedy marketed for weight loss without asking your doctor first, because some interact with prescribed medicines.
Frequently Asked Questions
Is retatrutide approved by the FDA?
No. Retatrutide is investigational and has not been approved by the FDA or any other regulator. Eli Lilly plans to file for approval in the first quarter of 2027, and a decision would not be due before about September 2027. It is available only to people enrolled in clinical trials, and it cannot legally be prescribed, bought, or compounded anywhere in the world.
How much weight did people lose on retatrutide?
In TRIUMPH-1, the highest dose cut body weight by 25.0% over 80 weeks, against 3.9% on placebo; among people who stayed on treatment the loss was 28.3%, and 45.3% lost at least 30% of their body weight. In type 2 diabetes, TRIUMPH-2 found 18.8% against 5.1%. A knee-osteoarthritis trial found pain eased as weight fell. These are trial averages, not a promise to any one person.
What are the most common side effects of retatrutide?
Digestive effects, which rise with the dose: nausea in 29 to 42% of people, diarrhoea in 25 to 34%, constipation in 24 to 26%, and vomiting in 11 to 25%. Skin tingling, called dysesthesia, affected 5 to 13%, and heart rate rose slightly. Most effects were mild to moderate, but about 11 in 100 people on the highest dose stopped the drug.
Is retatrutide better than Ozempic or Mounjaro?
Nobody knows yet: no head-to-head trial against semaglutide has been published, and the trial against tirzepatide, TRIUMPH-5, has not yet reported. Comparing trials can mislead, because the people and the years differ. The 25% average is the largest seen from any obesity medicine, but long-term safety is unknown; our guide to the FDA vision-loss warning for GLP-1 drugs has the newest safety news.
Can I buy retatrutide online?
No. Retatrutide is not legally available anywhere outside clinical trials. Products sold online as research peptides are not made by Eli Lilly, they are unregulated, and they may contain the wrong substance or the wrong strength, which can be dangerous. If you want a weight-loss medicine now, ask your doctor today about the approved options, semaglutide, tirzepatide or the orforglipron pill.
A Final Word
No weight-loss medicine has ever posted trial results like these, and still not one you can get. The results are real, the safety questions are open, and approval is at least a year away. Until then, the tools that work are already in your hands: food, movement, sleep and a doctor’s plan.
Medical Reviewer
Dr. Ata Ullah, MBBS, MD (Medicine) — Physician Consultant, Senior Medical Officer at DHQ Hospital, Layyah, Pakistan.
Motto: “Your Health, Our Responsibility.”
Online Consultation: Dr. Ata Ullah (MBBS, MD Medicine), Physician Consultant / Medical Specialist — WhatsApp: 0315 7148181 — Consultation Fees: $30

